Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - Union Minister Piyush Goyal Inaugurates Hunger Free World Initiative at Atal Bihari Vajpayee Kaushalya Vikas Kendra, Mumbai - CMR Green Technologies Limited Announced its Initial Public Offer (IPO) to open on June 3, 2026 At the Price Band of the Offer has been fixed at ₹ 182 to ₹ 192 per Equity Share - PM Modi's 12 Years: From Self-Reliant India to 'Make for the World' - Fadnavis, Chavan List Achievements - Sadbhavana Old Age Home needs ‘Mavtar’ The world’s largest ‘Vinubhai Bachubhai Nagrecha Campus’ Sadbhavana Old Age Home (Rajkot) requires childless, destitute, bedridden mavtar. Free admission will be given - Tata Realty and Salesforce Collaborate to Set New Benchmarks in AI-Led Customer Experience - Yami Gautam Dhar joins Surya Hospitals’ “The Amber Promise for Women’s Health” initiative during the launch of the Amber Wing at Santacruz Mumbai - Celebrating Innovation: HDFC SKY Shares Perspectives on India’s F&O Market Growth on National Technology Day - Rahul Shewale, Madhoo, Ashok Dhamankar and Mujtaba Aziz Naza Unveil the Latest Issue of ‘Society Interiors & Design’ Featuring Ar. Kavita & Ar. Soyuz Talib - Eugenix Hair Sciences celebrate 10 Years of Business Expansion Backed by 20,000+ Success Patients From a modest clinic in the Himalayan foothills to a name trusted across continents, Eugenix’s decade-long journey reflects a quiet revolution built on trust, innovation and patient-first care - VFS Global‑led consortium wins major citizen services contract to drive technology‑enabled transformation of 60 Model Sub‑Registrar Offices across Maharashtra

Woman Triumphs Over Lymphoma With CAR T Cell Therapy

She’s the first person in Andhra Pradesh to have successfully treated with indigenously built therapy

Navi Mumbai, 5 April 2024 (GNI) Despite being diagnosed with refractory diffuse large B-Cell lymphoma (DLBCL), 47-year-old Ms Reddi Lalitha Kumari from Bobbili town in Vizianagaram district of Andhra Pradesh, never took a day off from work in 24 years.

However, this dedicated high school Mathematics teacher’s journey was fraught with challenges– a testament to the complexity of refractory DLBCL. Refractory disease means the patient’s disease stopped responding to all the conventional treatment options that are available. In Ms Lalitha’s case, her cancer staged a fierce comeback, defying all standard therapies.

But her will to fight against the disease and her dream to see their twin daughters settle down in their lives, motivated Ms Lalitha to undergo CAR T Cell Therapy at Apollo Cancer Centre, Visakhapatnam.

The team led by Dr. Rakesh Reddy BoyaSenior Consultant – Medical & Hemato OncologyDr. Ventrapati PradeepConsultant – Medical Oncology, and Dr. G Veni PrasannaConsultant – Pathologist, explored advanced treatment options. According to Dr Boya, Ms. Lalitha’s case required a different approach due to the refractory nature of the disease and CAR-T Cell Therapy emerged as a viable option, offering a chance to be “cancer free.”

Dr. Rakesh Reddy Boya, Senior Consultant – Medical & Hemato Oncology, Apollo Cancer Centre, Vizag, said, “Following Ms Lalitha’s initial response to R-CHOP therapy, her relapse posed a formidable challenge. Through strategic intervention and the integration of salvage chemotherapy, including R-ICE, we achieved a remarkable complete response. It was through meticulous analysis, collaboration, and unwavering determination that we charted a path towards her recovery. This victory reinforces our commitment to pushing the boundaries of cancer care and providing hope to those in need.”

Following the CAR-T Cell therapy, Ms. Lalitha’s cancer led to a complete remission. “The most incredible news was hearing from the doctors – I am cancer-free. Being a maths teacher, I always believe that every problem has a solution and in my case, I got the right treatment at Apollo Cancer Centre,” she smiles. “This treatment has given me a second lease of life, and I’m incredibly grateful to the team at ACC for their expertise and unfaltering support.” ends GNI

Be the first to comment on "Woman Triumphs Over Lymphoma With CAR T Cell Therapy"

Leave a comment

Your email address will not be published.


*